Left cardiac sympathetic denervation in long QT syndrome: Analysis of therapeutic nonresponders

Circulation: Arrhythmia and Electrophysiology

Volumn 6, Issue 4, 2013, Pages 705-711

  Bos, J Martijn ^a   Bos, Katy M ^b   Johnson, Jonathan N ^b   Moir, Christopher ^b   Ackerman, Michael J ^a,b  

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Arrhythmias; Cardiac; Death sudden, cardiac; Left cardiac sympathetic denervation; Long QT syndrome; Syncope

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; NADOLOL; PROPRANOLOL;

ADOLESCENT; ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DENERVATION; DISEASE COURSE; ELECTRONIC MEDICAL RECORD; EVENT FREE SURVIVAL; FAINTNESS; FEMALE; FOLLOW UP; GENETIC SCREENING; GENOTYPE; HEART ARREST; HEART TRANSPLANTATION; HEART VENTRICLE FIBRILLATION; HIGH RISK PATIENT; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LONG QT SYNDROME; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PHENOTYPE; PRIMARY PREVENTION; PRIORITY JOURNAL; PTOSIS; QUALITY OF LIFE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SECONDARY PREVENTION; SEIZURE; SYMPATHETIC GANGLION; SYMPATHETIC TONE; SYMPATHETIC TRUNK; THORAX RADIOGRAPHY; TREATMENT INDICATION;

ARRHYTHMIAS, CARDIAC; DEATH SUDDEN, CARDIAC; LEFT CARDIAC SYMPATHETIC DENERVATION; LONG QT SYNDROME; SYNCOPE;

ADOLESCENT; ANALYSIS OF VARIANCE; ANTI-ARRHYTHMIA AGENTS; CHILD; CHILD, PRESCHOOL; DEFIBRILLATORS, IMPLANTABLE; DISEASE-FREE SURVIVAL; ELECTRIC COUNTERSHOCK; FEMALE; HEART; HUMANS; INFANT; INFANT, NEWBORN; KAPLAN-MEIER ESTIMATE; LONG QT SYNDROME; MALE; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SYMPATHECTOMY; SYMPATHETIC NERVOUS SYSTEM; TIME FACTORS; TREATMENT FAILURE; YOUNG ADULT;

EID: 84884508378     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.113.000102     Document Type: Article

References (18)

1. Ackerman MJ. Cardiac channelopathies: it's in the genes. Nat Med. 2004;10: 463-464.
2. Schwartz PJ, Stramba-Badiale M, Crotti L, Pedrazzini M, Besana A, Bosi G, Gabbarini F, Goulene K, Insolia R, Mannarino S, Mosca F, Nespoli L, Rimini A, Rosati E, Salice P, Spazzolini C. Prevalence of the congenital long-QT syndrome. Circulation. 2009;120: 1761-1767.
3. Kapplinger JD, Tester DJ, Salisbury BA, Carr JL, Harris-Kerr C, Pollevick GD, Wilde AA, Ackerman MJ. Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test. Heart Rhythm. 2009;6: 1297-1303.
4. Collura CA, Johnson JN, Moir C, Ackerman MJ. Left cardiac sympathetic denervation for the treatment of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia using video-assisted thoracic surgery. Heart Rhythm. 2009;6: 752-759.
5. Moss AJ, McDonald J. Unilateral cervicothoracic sympathetic ganglionectomy for the treatment of long QT interval syndrome. N Engl J Med. 1971;285: 903-904.
6. Schwartz PJ, Priori SG, Cerrone M, Spazzolini C, Odero A, Napolitano C, Bloise R, De Ferrari GM, Klersy C, Moss AJ, Zareba W, Robinson JL, Hall WJ, Brink PA, Toivonen L, Epstein AE, Li C, Hu D. Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome. Circulation. 2004;109: 1826-1833.
7. Wilde AA, Bhuiyan ZA, Crotti L, Facchini M, De Ferrari GM, Paul T, Ferrandi C, Koolbergen DR, Odero A, Schwartz PJ. Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia. N Engl J Med. 2008;358: 2024-2029.
8. Khositseth A, Schwartz PJ, Tester DJ, Ackerman MJ. Congenital long QT syndrome. In: Gussak I, Antzelevitch C, eds. Electrical Diseases of the Heart; Genetics, Mechanisms, Treatment, Prevention. New York, NY: Springer Publishing; 2008: 462-482.
9. Schwartz PJ, Billman GE, Stone HL. Autonomic mechanisms in ventricular fibrillation induced by myocardial ischemia during exercise in dogs with healed myocardial infarction. An experimental preparation for sudden cardiac death. Circulation. 1984;69: 790-800.
10. Schwartz PJ. The rationale and the role of left stellectomy for the prevention of malignant arrhythmias. Ann N Y Acad Sci. 1984;427: 199-221.
11. Schwartz PJ, Snebold NG, Brown AM. Effects of unilateral cardiac sympathetic denervation on the ventricular fibrillation threshold. Am J Cardiol. 1976;37: 1034-1040.
12. Schwartz PJ, Locati EH, Moss AJ, Crampton RS, Trazzi R, Ruberti U. Left cardiac sympathetic denervation in the therapy of congenital long QT syndrome. A worldwide report. Circulation. 1991;84: 503-511.
13. Bourke T, Vaseghi M, Michowitz Y, Sankhla V, Shah M, Swapna N, Boyle NG, Mahajan A, Narasimhan C, Lokhandwala Y, Shivkumar K. Neuraxial modulation for refractory ventricular arrhythmias: value of thoracic epidural anesthesia and surgical left cardiac sympathetic denervation. Circulation. 2010;121: 2255-2262.
14. Johnson JN, Harris KM, Moir C, Lau YR, Ackerman MJ. Left cardiac sympathetic denervation in a pediatric patient with hypertrophic cardiomyopathy and recurrent ventricular fibrillation. Heart Rhythm. 2011;8: 1591-1594.
15. Moss AJ, Zareba W, Hall WJ, Schwartz PJ, Crampton RS, Benhorin J, Vincent GM, Locati EH, Priori SG, Napolitano C, Medina A, Zhang L, Robinson JL, Timothy K, Towbin JA, Andrews ML. Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation. 2000;101: 616-623.
16. Priori SG, Napolitano C, Schwartz PJ, Grillo M, Bloise R, Ronchetti E, Moncalvo C, Tulipani C, Veia A, Bottelli G, Nastoli J. Association of long QT syndrome loci and cardiac events among patients treated with betablockers. JAMA. 2004;292: 1341-1344.
17. Chatrath R, Bell CM, Ackerman MJ. Beta-blocker therapy failures in symptomatic probands with genotyped long-QT syndrome. Pediatr Cardiol. 2004;25: 459-465.
18. Schwartz PJ, Spazzolini C, Crotti L. All LQT3 patients need an ICD: true or false? Heart Rhythm. 2009;6: 113-120.